ghk-cu peptide side effects high dose Dosage: Protocols & Charts GHK-CU Peptide Dosage Chart: Complete
Description
they see it as a data point


Long-Term Considerations While clinical trials up to 24 weeks demonstrate excellent safety, data on continuous use beyond 6-12 months remains limited

[DOI] [PMC free article] [PubMed] [Google Scholar] 57.Sikiric P., Jelovac N., Jelovac-Gjeldum A., Dodig G., Staresinic M., Anic T., Zoricic I., Ferovic D., Buljat G., Prkacin I., et al

HUBERMAN: For instance, activating one pathway for cellular growth and another pathway for cell migration, for the cell to actually move, and maybe another pathway to talk to another cell to stimulate, say, the growth of blood vessels